BLC PAR Week ended 07 Aug 2026

Weekly Investor Report

Bastide Le Confort Médical SA · Healthcare · Medical Distribution

Open interactive chart View report data
Latest close 22.75 EUR
-2.8% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -6.6% below the Trend Line and sits at 11.0% of its 52-week range. The latest completed week returned -2.8%, after a -2.6% four-week move. The latest news-sentiment score is 50/100.

Setup score 33 out of 100
Latest Close 22.75 EUR 7 Aug 2026
1W Return -2.8% latest completed week
4W Return -2.6% short-term follow-through
12W Return -16.8% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.8% Latest completed week; four-week move -2.6%. Indicator stack 8/30 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 2 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -6.6% below the Trend Line and sits at 11.0% of its 52-week range. The latest completed week returned -2.8%, after a -2.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2212-week average 0.31

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.6% over four weeks, -16.8% over 12 weeks, and -21.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.8%
4W-2.6%
12W-16.8%
26W3.4%
52W-21.1%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.85Latest activity-pressure read.
Pressure change-54.3%Four-week change in activity pressure.
Leadership-14.04Latest relative-leadership reading.
RS change-34.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 2 relevant articles.

0 positive · 2 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-22.2%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+10.5%Week of 13 Feb.
Worst week-5.8%Week of 6 Mar.
Latest week-2.8%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses8
Sharp losses5
Recent vol3.2%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryFR Medical Distribution
4-week rank2 / 2
Group average2.0%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD0.0%positive activity pressure
RS50.0%positive relative leadership

Four-week leaders

ALEMG · PAR6.6%BLC · PAR-2.6%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 4/12, activity pressure 4/12, relative leadership 1/12.

Activity pressure 0.22; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 2 relevant articles.

Groupe Bastide sells New Medical Concept, the holding company of EXPERF group Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202622.75 EUR-2.8%24.36 EUR23.61 EUR-0.85-14.0410.2KOff
31 Jul 202623.40 EUR1.7%24.46 EUR23.64 EUR-0.86-10.088.5KOff
24 Jul 202623.00 EUR-2.3%24.47 EUR23.67 EUR-0.84-10.835.4KOff
17 Jul 202623.55 EUR0.9%24.49 EUR23.70 EUR-0.61-9.034.2KOff
10 Jul 202623.35 EUR-3.7%24.52 EUR23.72 EUR-0.55-10.456.7KOff
3 Jul 202624.25 EUR-2.4%24.58 EUR23.75 EUR-0.49-9.591.4KOff
26 Jun 202624.85 EUR6.9%24.63 EUR23.78 EUR-0.39-6.678.0KOff
19 Jun 202623.25 EUR-1.3%24.67 EUR23.81 EUR-0.24-13.523.0KOff
12 Jun 202623.55 EUR-4.8%24.73 EUR23.85 EUR0.20-12.332.3KOn
5 Jun 202624.75 EUR-2.2%24.82 EUR23.89 EUR0.63-6.941.2KOn
29 May 202625.30 EUR-4.3%24.81 EUR23.92 EUR1.00-4.8610.1KOn
22 May 202626.45 EUR-3.3%24.79 EUR23.94 EUR1.090.0812.1KOn
15 May 202627.35 EUR2.4%24.71 EUR23.97 EUR0.935.3211.5KOn
8 May 202626.70 EUR6.6%24.60 EUR24.00 EUR0.880.7223.5KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context